CN
CN
CN

News 2026-09-15

Porton Chongqing Liangjiang Drug Product Manufacturing Site Earns Recertification of ISO 14001 & ISO 45001

Standardizing System Operations, Maintaining Certification Qualifications


Recently, Porton Chongqing Liangjiang Drug Product Manufacturing Site successfully passed the recertification audit for ISO 14001 (Environmental Management System) and ISO 45001 (Occupational Health and Safety Management System), maintaining its dual-system certification status.


The site first obtained dual-system certification on August 23, 2023, marking a significant milestone in advancing its EHS management systems from framework establishment to authoritative certification.

This successful recertification highlights the standardized operation of the site's management systems, the rigor of its on-site management, and the robustness of its risk control mechanisms, further validating the continued effectiveness of the dual systems.





Rigorous On-Site Audits, Ensuring Continuous Effectiveness

Covering an area of 34,000 m², Porton Chongqing Liangjiang Drug Product Manufacturing Site serves as an integrated end-to-end Drug Product CDMO platform under Porton Pharma Solutions. Adhering to US, EU, and Chinese GMP standards, the site is equipped with advanced international R&D equipment and analytical instruments. Backed by an experienced Drug Product team, it offers comprehensive drug lifecycle solutions for oral solid dosage forms, injection (lyophilized and liquid), and topical semi-solid dosage forms from early clinical stages to commercial supply, supporting OEB 1~4 products.


During the audit, the expert panel conducted a thorough and rigorous evaluation covering key areas such as environmental control, energy conservation, occupational health, operational safety, and risk prevention. Through document reviews, on-site inspections, and process tracing, the panel confirmed that the dual management systems of Porton Chongqing Liangjiang Drug Product Manufacturing Site are in line with standard requirements.


Deepening System Operations, Empowering Future Development


Successfully passing the ISO 14001 Environmental Management System and ISO 45001 Occupational Health and Safety Management System recertification audit not only provides strong recognition of the site's EHS performance, but also injects new momentum into its path toward high-quality development.

Fentian Zhou, General Manager of Porton Chongqing Liangjiang Drug Product Manufacturing Site and R&D Center, stated, "Achieving recertification for the dual management systems underscores our unwavering commitment to standardized management, safety, environmental protection, and sustainability. This not only enhances our operational resilience, but also provides our clients with robust quality assurance. We remain dedicated to supporting our clients throughout the entire drug lifecycle—from R&D to commercialization—with higher standards, more reliable services, and guaranteed supply security and compliance."

Standing at a new starting point, Porton will take this opportunity to further strengthen the operation of our dual management systems. Upholding high standards for greater environmental sustainability, safety and compliance, we will steadily advance our sustainable development and deliver greater value to our customers.

Become part of Porton's community to access personalized insights and resources.
Subscribe to the Newsletter
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.

This website contains product information intended for different regions and may include details that are not available or authorized in your country. Please be aware that we assume no responsibility for any access to such information that may contravene applicable laws, regulations, or usage restrictions in your jurisdiction.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.
US: (609) 860-1300
CN: (86) 23-8608-3200